Infinity Pharmaceuticals reported $53.12M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 7183M 655M
AstraZeneca AZN:LN 4817M 945M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Cytori Therapeutics CYTX:US $ 18.09M 3.15M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Gilead Sciences GILD:US $ 7000M 2704M
GlaxoSmithKline GSK:LN 6465M 4502M
Infinity Pharmaceuticals INFI:US $ 53.12M 27.6M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Novartis NOVN:VX SF 3625M 10227M
Seattle Genetics SGEN:US $ 364.87M 103.88M
Tg Therapeutics TGTX:US $ 185.68M 113.21M
Vascular Biogenics VBLT:US 13.25M 8.73M
YTE INCY:US $ 2435.38M 178.62M